BOT 1.54% 32.0¢ botanix pharmaceuticals ltd

Ann: Botanix Announces BTX 1503 Data and Progression to Phase 3, page-195

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 800 Posts.
    lightbulb Created with Sketch. 383
    This isn't a very clear cut data set.

    However, it isn't doom n gloom. rather, they showed a significant effect on non-inflammatory lesions in both cohorts. the secondary data readout.

    If just looking at the AUS data, there's a significant effect in both inflammatory and non-inflammatory lesions.

    They need to clarify the placebo and vehicle, I don't really understand how a placebo effect can be so substantial.

    safety profile is good.

    it works. just not as well in inflammatory lesions as we may have hoped across both Australian and American cohorts.....
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
(20min delay)
Last
32.0¢
Change
-0.005(1.54%)
Mkt cap ! $581.5M
Open High Low Value Volume
32.5¢ 33.0¢ 32.0¢ $1.058M 3.280M

Buyers (Bids)

No. Vol. Price($)
2 147750 32.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.5¢ 632850 6
View Market Depth
Last trade - 16.10pm 13/11/2024 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.